| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| (loss) income from operations before income taxes | -1,475 | -14,352 | ||
| Income tax benefit (expense) | - | 0 | ||
| Net (loss) income | -1,475 | -14,352 | ||
| Loss from operations attributed to noncontrolling interest | -5 | -6 | ||
| Net (loss) income attributable to common stockholders | -1,470 | -14,346 | ||
| Basic | -0.12 | -1.18 | ||
| Basic | 12,185,412 | 12,185,412 | ||
| Diluted | -0.12 | -1.18 | ||
IMPACT BIOMEDICAL INC. (IBO)
IMPACT BIOMEDICAL INC. (IBO)